Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Total Non-Current Liabilities (2023 - 2025)

Bioharvest Sciences has reported Total Non-Current Liabilities over the past 3 years, most recently at $14.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 54.39% year-over-year to $14.5 million; the TTM value through Dec 2025 reached $14.5 million, up 54.39%, while the annual FY2025 figure was $14.5 million, 54.39% up from the prior year.
  • Total Non-Current Liabilities was $14.5 million for Q4 2025 at Bioharvest Sciences, up from $14.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $14.9 million in Q2 2025 and bottomed at $3.4 million in Q4 2023.
  • The 3-year median for Total Non-Current Liabilities is $11.4 million (2024), against an average of $10.8 million.
  • Year-over-year, Total Non-Current Liabilities skyrocketed 177.83% in 2024 and then dropped 9.34% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $3.4 million in 2023, then skyrocketed by 177.83% to $9.4 million in 2024, then soared by 54.39% to $14.5 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $14.5 million (Q4 2025), $14.3 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.